Unknown

Dataset Information

0

Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report.


ABSTRACT: Background: Pulmonary complications of sickle cell disease (SCD) are diverse and encompass acute and chronic disease. The understanding of the natural history of pulmonary complications of SCD is limited, no specific therapies exist, and these complications are a primary cause of morbidity and mortality.Methods: We gathered a multidisciplinary group of pediatric and adult hematologists, pulmonologists, and emergency medicine physicians with expertise in SCD-related lung disease along with an SCD patient advocate for an American Thoracic Society-sponsored workshop to review the literature and identify key unanswered clinical and research questions. Participants were divided into four subcommittees on the basis of expertise: 1) acute chest syndrome, 2) lower airways disease and pulmonary function, 3) sleep-disordered breathing and hypoxia, and 4) pulmonary vascular complications of SCD. Before the workshop, a comprehensive literature review of each subtopic was conducted. Clinically important questions were developed after literature review and were finalized by group discussion and consensus.Results: Current knowledge is based on small, predominantly observational studies, few multicenter longitudinal studies, and even fewer high-quality interventional trials specifically targeting the pulmonary complications of SCD. Each subcommittee identified the three or four most important unanswered questions in their topic area for researchers to direct the next steps of clinical investigation.Conclusions: Important and clinically relevant questions regarding sickle cell lung disease remain unanswered. High-quality, multicenter, longitudinal studies and randomized clinical trials designed and implemented by teams of multidisciplinary clinician-investigators are needed to improve the care of individuals with SCD.

SUBMITTER: Ruhl AP 

PROVIDER: S-EPMC6812163 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report.

Ruhl A Parker AP   Sadreameli S Christy SC   Allen Julian L JL   Bennett Debra P DP   Campbell Andrew D AD   Coates Thomas D TD   Diallo Dapa A DA   Field Joshua J JJ   Fiorino Elizabeth K EK   Gladwin Mark T MT   Glassberg Jeffrey A JA   Gordeuk Victor R VR   Graham Leroy M LM   Greenough Anne A   Howard Jo J   Kato Gregory J GJ   Knight-Madden Jennifer J   Kopp Benjamin T BT   Koumbourlis Anastassios C AC   Lanzkron Sophie M SM   Liem Robert I RI   Machado Roberto F RF   Mehari Alem A   Morris Claudia R CR   Ogunlesi Folasade O FO   Rosen Carol L CL   Smith-Whitley Kim K   Tauber Danna D   Terry Nancy N   Thein Swee Lay SL   Vichinsky Elliott E   Weir Nargues A NA   Cohen Robyn T RT   Klings Elizabeth S ES  

Annals of the American Thoracic Society 20190901 9


<b>Background:</b> Pulmonary complications of sickle cell disease (SCD) are diverse and encompass acute and chronic disease. The understanding of the natural history of pulmonary complications of SCD is limited, no specific therapies exist, and these complications are a primary cause of morbidity and mortality.<b>Methods:</b> We gathered a multidisciplinary group of pediatric and adult hematologists, pulmonologists, and emergency medicine physicians with expertise in SCD-related lung disease alo  ...[more]

Similar Datasets

| S-EPMC5946685 | biostudies-literature
| S-EPMC7706597 | biostudies-literature
| S-EPMC6812156 | biostudies-literature
| S-EPMC5946579 | biostudies-literature
| S-EPMC5566295 | biostudies-literature
| S-EPMC7958519 | biostudies-literature
| S-EPMC6775885 | biostudies-literature
| S-EPMC5466184 | biostudies-literature
| S-EPMC6072613 | biostudies-literature
| S-EPMC6774741 | biostudies-other